We suggest that the chronic depletion of c-Myc, brought about by salicylate-dependent AMPK activation, could account for the chemopreventive effect of aspirin on colorectal cancer, indicating a possible way forward for the therapeutic targeting of oncogenic Myc. Here, PRKAA2 is linked to colorectal cancer.